{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:17:16Z","timestamp":1791101836013,"version":"4.1.0"},"reference-count":40,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4]]},"abstract":"<jats:p>\n                    Blastic plasmacytoid dendritic cell neoplasm is a rare entity grouped with the acute myeloid leukemia\u2013related precursor neoplasms in the 2008 World Health Organization classification. It was previously postulated to originate from natural killer cells, T cells, or monocytes but is now believed to arise from the plasmacytoid dendritic cell. The pathogenesis of blastic plasmacytoid dendritic cell neoplasm is not well understood, although the neoplasm demonstrates frequent deletion of tumor suppressor genes, including\n                    <jats:italic>RB1<\/jats:italic>\n                    ,\n                    <jats:italic>CDKN1B<\/jats:italic>\n                    ,\n                    <jats:italic>CDKN2A<\/jats:italic>\n                    , and\n                    <jats:italic>TP53<\/jats:italic>\n                    . Blastic plasmacytoid dendritic cell neoplasm is a clinically aggressive tumor that often initially presents as cutaneous lesions and subsequently progresses to bone marrow involvement and leukemic dissemination. It is characterized by enhanced expression of CD56, CD4, and CD123, which can be detected by flow cytometry\/immunohistochemistry. The differential diagnoses include myeloid sarcoma\/acute myeloid leukemia, T-cell lymphoblastic leukemia\/lymphoma, NK-cell lymphoma\/leukemia, and some mature T-cell lymphomas\/leukemias. Patients usually respond to initial chemotherapy but often relapse. Stem cell transplant may improve survival.\n                  <\/jats:p>","DOI":"10.5858\/arpa.2013-0101-rs","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T21:18:38Z","timestamp":1396041518000},"page":"564-569","source":"Crossref","is-referenced-by-count":61,"title":["Blastic Plasmacytoid Dendritic Cell Neoplasm: A Clinicopathologic Review"],"prefix":"10.5858","volume":"138","author":[{"given":"Yang","family":"Shi","sequence":"first","affiliation":[{"name":"From the Department of Pathology, Duke University Medical Center, Durham, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endi","family":"Wang","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, Duke University Medical Center, Durham, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","reference":[{"issue":"5","key":"i1543-2165-138-4-564-b01","series-title":"Am J Clin Pathol","first-page":"687","article-title":"CD4+\/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells","volume":"127","author":"Herling\n              M,","year":"2007","unstructured":"Herling\n              M, \n            \n              Jones\n              D. \n          \n          CD4+\/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells. Am J Clin Pathol. 2007;127(5):687\u2013700."},{"key":"i1543-2165-138-4-564-b02","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed","first-page":"146","article-title":"Blastic plasmacytoid dendritic cells neoplasm","author":"Facchetti\n              F,","year":"2008","unstructured":"Facchetti\n              F, \n            \n              Jones\n              DM, \n            \n              Petrella\n              T. \n          \n          Blastic plasmacytoid dendritic cells neoplasm. In: SwerdlowSH, CampoE, HarrisNL, JaffeES, PileriSA, SteinH, ThieleJ, VardimanJW, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon France: IARC Press;2008:146\u2013147. World Health Organization Classification of Tumours; vol 2."},{"issue":"5","key":"i1543-2165-138-4-564-b03","series-title":"Blood","first-page":"1556","article-title":"Clinical and biologic features of CD4+CD56+ malignancies","volume":"99","author":"Feuillard\n              J,","year":"2002","unstructured":"Feuillard\n              J, \n            \n              Jacob\n              MC, \n            \n              Valensi\n              F, \n            et al\n          . Clinical and biologic features of CD4+CD56+ malignancies. Blood. 2002;99(5):1556\u20131563."},{"issue":"8","key":"i1543-2165-138-4-564-b04","series-title":"Haematologica","first-page":"941","article-title":"CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells","volume":"88","author":"Jacob\n              MC,","year":"2003","unstructured":"Jacob\n              MC, \n            \n              Chaperot\n              L, \n            \n              Mossuz\n              P, \n            et al\n          . CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells. Haematologica. 2003;88(8):941\u2013955."},{"issue":"5","key":"i1543-2165-138-4-564-b05","series-title":"Am J Clin Pathol","first-page":"662","article-title":"Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review","volume":"123","author":"Petrella\n              T,","year":"2005","unstructured":"Petrella\n              T, \n            \n              Bagot\n              M, \n            \n              Willemze\n              R, \n            et al\n          . Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Am J Clin Pathol. 2005;123(5):662\u2013675."},{"issue":"2","key":"i1543-2165-138-4-564-b06","series-title":"Acta Haematol","first-page":"124","article-title":"Blastic plasmacytoid dendritic cell neoplasm without cutaneous lesion at presentation: case report and literature review","volume":"127","author":"Wang\n              H,","year":"2012","unstructured":"Wang\n              H, \n            \n              Cao\n              J, \n            \n              Hong\n              X. \n          \n          Blastic plasmacytoid dendritic cell neoplasm without cutaneous lesion at presentation: case report and literature review. Acta Haematol. 2012;127(2):124\u2013127."},{"issue":"12","key":"i1543-2165-138-4-564-b07","series-title":"Blood","first-page":"5007","article-title":"TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin","volume":"101","author":"Herling\n              M,","year":"2003","unstructured":"Herling\n              M, \n            \n              Teitell\n              MA, \n            \n              Shen\n              RR, \n            \n              Medeiros\n              LJ, \n            \n              Jones\n              D. \n          \n          TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin. Blood. 2003;101(12):5007\u20135009."},{"issue":"9","key":"i1543-2165-138-4-564-b08","series-title":"J Clin Pathol","first-page":"981","article-title":"CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer","volume":"60","author":"Assaf\n              C,","year":"2007","unstructured":"Assaf\n              C, \n            \n              Gellrich\n              S, \n            \n              Whittaker\n              S, \n            et al\n          . CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer. J Clin Pathol. 2007;60(9):981\u2013989."},{"issue":"7","key":"i1543-2165-138-4-564-b09","series-title":"Am J Surg Pathol","first-page":"852","article-title":"\u2018Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes","volume":"26","author":"Petrella\n              T,","year":"2002","unstructured":"Petrella\n              T, \n            \n              Comeau\n              MR, \n            \n              Maynadie\n              M, \n            et al\n          . \u2018Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol. 2002;26(7):852\u2013862."},{"issue":"2","key":"i1543-2165-138-4-564-b10","series-title":"Am J Surg Pathol","first-page":"137","article-title":"CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity?: Groupe Fran\u00e7ais d'Etude des Lymphomes Cutan\u00e9s (GFELC)","volume":"23","author":"Petrella\n              T,","year":"1999","unstructured":"Petrella\n              T, \n            \n              Dalac\n              S, \n            \n              Maynadie\n              M, \n            et al\n          . CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity?: Groupe Fran\u00e7ais d'Etude des Lymphomes Cutan\u00e9s (GFELC). Am J Surg Pathol. 1999;23(2):137\u2013146."},{"issue":"2","key":"i1543-2165-138-4-564-b11","series-title":"Am J Clin Pathol","first-page":"307","article-title":"TCL1 and CLA expression in agranular CD4\/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis","volume":"122","author":"Petrella\n              T,","year":"2004","unstructured":"Petrella\n              T, \n            \n              Meijer\n              CJ, \n            \n              Dalac\n              S, \n            et al\n          . TCL1 and CLA expression in agranular CD4\/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis. Am J Clin Pathol. 2004;122(2):307\u2013313."},{"issue":"1","key":"i1543-2165-138-4-564-b12","series-title":"Am J Surg Pathol","first-page":"75","article-title":"Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients","volume":"34","author":"Cota\n              C,","year":"2010","unstructured":"Cota\n              C, \n            \n              Vale\n              E, \n            \n              Viana\n              I, \n            et al\n          . Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients. Am J Surg Pathol. 2010;34(1):75\u201387."},{"issue":"11","key":"i1543-2165-138-4-564-b13","series-title":"Blood","first-page":"4154","article-title":"CD4+, CD56+ DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique","volume":"99","author":"Leroux\n              D,","year":"2002","unstructured":"Leroux\n              D, \n            \n              Mugneret\n              F, \n            \n              Callanan\n              M, \n            et al\n          . CD4+, CD56+ DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique. Blood. 2002;99(11):4154\u20134159."},{"issue":"17","key":"i1543-2165-138-4-564-b14","series-title":"Blood","first-page":"4591","article-title":"Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion","volume":"118","author":"Lucioni\n              M,","year":"2011","unstructured":"Lucioni\n              M, \n            \n              Novara\n              F, \n            \n              Fiandrino\n              G, \n            et al\n          . Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion. Blood. 2011;118(17):4591\u20134594."},{"issue":"6","key":"i1543-2165-138-4-564-b15","series-title":"J Exp Med","first-page":"1101","article-title":"The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand","volume":"185","author":"Grouard\n              G,","year":"1997","unstructured":"Grouard\n              G, \n            \n              Rissoan\n              MC, \n            \n              Filgueira\n              L, \n            \n              Durand\n              I, \n            \n              Banchereau\n              J, \n            \n              Liu\n              YJ. \n          \n          The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med. 1997;185(6):1101\u20131111."},{"issue":"6","key":"i1543-2165-138-4-564-b16","series-title":"Adv Anat Pathol","first-page":"392","article-title":"Plasmacytoid dendritic cells: physiologic roles and pathologic states","volume":"16","author":"Jegalian\n              AG,","year":"2009","unstructured":"Jegalian\n              AG, \n            \n              Facchetti\n              F, \n            \n              Jaffe\n              ES. \n          \n          Plasmacytoid dendritic cells: physiologic roles and pathologic states. Adv Anat Pathol. 2009;16(6):392\u2013404."},{"issue":"3","key":"i1543-2165-138-4-564-b17","series-title":"Autoimmunity","first-page":"210","article-title":"Tumoral aspects of plasmacytoid dendritic cells: what do we know in 2009?","volume":"43","author":"Petrella\n              T,","year":"2010","unstructured":"Petrella\n              T, \n            \n              Facchetti\n              F. \n          \n          Tumoral aspects of plasmacytoid dendritic cells: what do we know in 2009?\n          Autoimmunity. 2010;43(3):210\u2013214."},{"issue":"3","key":"i1543-2165-138-4-564-b18","series-title":"Br J Haematol","first-page":"413","article-title":"TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm","volume":"153","author":"Jardin\n              F,","year":"2011","unstructured":"Jardin\n              F, \n            \n              Ruminy\n              P, \n            \n              Parmentier\n              F, \n            et al\n          . TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm. Br J Haematol. 2011;153(3):413\u2013416."},{"issue":"3","key":"i1543-2165-138-4-564-b19","series-title":"Blood","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1182\/blood-2012-08-448613","article-title":"European Group for Blood and Marrow Transplantation Lymphoma, Pediatric Diseases, and Acute Leukemia Working Parties. Stem cell transplantation can provide durable disease control in Blastic plasmacytoid dendritic cell neoplasm (BPDCN) [published online ahead of print November 30, 2012]","volume":"121","author":"Roos-Weil\n              D,","year":"2013","unstructured":"Roos-Weil\n              D, \n            \n              Dietrich\n              S, \n            \n              Boumendil\n              A, \n            et al;\n          \n          European Group for Blood and Marrow Transplantation Lymphoma, Pediatric Diseases, and Acute Leukemia Working Parties. Stem cell transplantation can provide durable disease control in Blastic plasmacytoid dendritic cell neoplasm (BPDCN) [published online ahead of print November 30, 2012]. Blood. 2013;121(3):440\u2013446. doi:10.1182\/blood-2012-08-448613."},{"issue":"11","key":"i1543-2165-138-4-564-b20","series-title":"Haematologica","first-page":"1873","article-title":"Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications","volume":"95","author":"Jegalian\n              AG,","year":"2010","unstructured":"Jegalian\n              AG, \n            \n              Buxbaum\n              NP, \n            \n              Facchetti\n              F, \n            et al\n          . Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications. Haematologica. 2010;95(11):1873\u20131879."},{"issue":"5","key":"i1543-2165-138-4-564-b01","series-title":"Am J Clin Pathol","first-page":"687","article-title":"CD4+\/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells","volume":"127","author":"Herling\n              M,","year":"2007","unstructured":"Herling\n              M, \n            \n              Jones\n              D. \n          \n          CD4+\/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells. Am J Clin Pathol. 2007;127(5):687\u2013700."},{"key":"i1543-2165-138-4-564-b02","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed","first-page":"146","article-title":"Blastic plasmacytoid dendritic cells neoplasm","author":"Facchetti\n              F,","year":"2008","unstructured":"Facchetti\n              F, \n            \n              Jones\n              DM, \n            \n              Petrella\n              T. \n          \n          Blastic plasmacytoid dendritic cells neoplasm. In: SwerdlowSH, CampoE, HarrisNL, JaffeES, PileriSA, SteinH, ThieleJ, VardimanJW, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon France: IARC Press;2008:146\u2013147. World Health Organization Classification of Tumours; vol 2."},{"issue":"5","key":"i1543-2165-138-4-564-b03","series-title":"Blood","first-page":"1556","article-title":"Clinical and biologic features of CD4+CD56+ malignancies","volume":"99","author":"Feuillard\n              J,","year":"2002","unstructured":"Feuillard\n              J, \n            \n              Jacob\n              MC, \n            \n              Valensi\n              F, \n            et al\n          . Clinical and biologic features of CD4+CD56+ malignancies. Blood. 2002;99(5):1556\u20131563."},{"issue":"8","key":"i1543-2165-138-4-564-b04","series-title":"Haematologica","first-page":"941","article-title":"CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells","volume":"88","author":"Jacob\n              MC,","year":"2003","unstructured":"Jacob\n              MC, \n            \n              Chaperot\n              L, \n            \n              Mossuz\n              P, \n            et al\n          . CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells. Haematologica. 2003;88(8):941\u2013955."},{"issue":"5","key":"i1543-2165-138-4-564-b05","series-title":"Am J Clin Pathol","first-page":"662","article-title":"Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review","volume":"123","author":"Petrella\n              T,","year":"2005","unstructured":"Petrella\n              T, \n            \n              Bagot\n              M, \n            \n              Willemze\n              R, \n            et al\n          . Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Am J Clin Pathol. 2005;123(5):662\u2013675."},{"issue":"2","key":"i1543-2165-138-4-564-b06","series-title":"Acta Haematol","first-page":"124","article-title":"Blastic plasmacytoid dendritic cell neoplasm without cutaneous lesion at presentation: case report and literature review","volume":"127","author":"Wang\n              H,","year":"2012","unstructured":"Wang\n              H, \n            \n              Cao\n              J, \n            \n              Hong\n              X. \n          \n          Blastic plasmacytoid dendritic cell neoplasm without cutaneous lesion at presentation: case report and literature review. Acta Haematol. 2012;127(2):124\u2013127."},{"issue":"12","key":"i1543-2165-138-4-564-b07","series-title":"Blood","first-page":"5007","article-title":"TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin","volume":"101","author":"Herling\n              M,","year":"2003","unstructured":"Herling\n              M, \n            \n              Teitell\n              MA, \n            \n              Shen\n              RR, \n            \n              Medeiros\n              LJ, \n            \n              Jones\n              D. \n          \n          TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin. Blood. 2003;101(12):5007\u20135009."},{"issue":"9","key":"i1543-2165-138-4-564-b08","series-title":"J Clin Pathol","first-page":"981","article-title":"CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer","volume":"60","author":"Assaf\n              C,","year":"2007","unstructured":"Assaf\n              C, \n            \n              Gellrich\n              S, \n            \n              Whittaker\n              S, \n            et al\n          . CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer. J Clin Pathol. 2007;60(9):981\u2013989."},{"issue":"7","key":"i1543-2165-138-4-564-b09","series-title":"Am J Surg Pathol","first-page":"852","article-title":"\u2018Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes","volume":"26","author":"Petrella\n              T,","year":"2002","unstructured":"Petrella\n              T, \n            \n              Comeau\n              MR, \n            \n              Maynadie\n              M, \n            et al\n          . \u2018Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol. 2002;26(7):852\u2013862."},{"issue":"2","key":"i1543-2165-138-4-564-b10","series-title":"Am J Surg Pathol","first-page":"137","article-title":"CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity?: Groupe Fran\u00e7ais d'Etude des Lymphomes Cutan\u00e9s (GFELC)","volume":"23","author":"Petrella\n              T,","year":"1999","unstructured":"Petrella\n              T, \n            \n              Dalac\n              S, \n            \n              Maynadie\n              M, \n            et al\n          . CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity?: Groupe Fran\u00e7ais d'Etude des Lymphomes Cutan\u00e9s (GFELC). Am J Surg Pathol. 1999;23(2):137\u2013146."},{"issue":"2","key":"i1543-2165-138-4-564-b11","series-title":"Am J Clin Pathol","first-page":"307","article-title":"TCL1 and CLA expression in agranular CD4\/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis","volume":"122","author":"Petrella\n              T,","year":"2004","unstructured":"Petrella\n              T, \n            \n              Meijer\n              CJ, \n            \n              Dalac\n              S, \n            et al\n          . TCL1 and CLA expression in agranular CD4\/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis. Am J Clin Pathol. 2004;122(2):307\u2013313."},{"issue":"1","key":"i1543-2165-138-4-564-b12","series-title":"Am J Surg Pathol","first-page":"75","article-title":"Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients","volume":"34","author":"Cota\n              C,","year":"2010","unstructured":"Cota\n              C, \n            \n              Vale\n              E, \n            \n              Viana\n              I, \n            et al\n          . Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients. Am J Surg Pathol. 2010;34(1):75\u201387."},{"issue":"11","key":"i1543-2165-138-4-564-b13","series-title":"Blood","first-page":"4154","article-title":"CD4+, CD56+ DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique","volume":"99","author":"Leroux\n              D,","year":"2002","unstructured":"Leroux\n              D, \n            \n              Mugneret\n              F, \n            \n              Callanan\n              M, \n            et al\n          . CD4+, CD56+ DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique. Blood. 2002;99(11):4154\u20134159."},{"issue":"17","key":"i1543-2165-138-4-564-b14","series-title":"Blood","first-page":"4591","article-title":"Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion","volume":"118","author":"Lucioni\n              M,","year":"2011","unstructured":"Lucioni\n              M, \n            \n              Novara\n              F, \n            \n              Fiandrino\n              G, \n            et al\n          . Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion. Blood. 2011;118(17):4591\u20134594."},{"issue":"6","key":"i1543-2165-138-4-564-b15","series-title":"J Exp Med","first-page":"1101","article-title":"The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand","volume":"185","author":"Grouard\n              G,","year":"1997","unstructured":"Grouard\n              G, \n            \n              Rissoan\n              MC, \n            \n              Filgueira\n              L, \n            \n              Durand\n              I, \n            \n              Banchereau\n              J, \n            \n              Liu\n              YJ. \n          \n          The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med. 1997;185(6):1101\u20131111."},{"issue":"6","key":"i1543-2165-138-4-564-b16","series-title":"Adv Anat Pathol","first-page":"392","article-title":"Plasmacytoid dendritic cells: physiologic roles and pathologic states","volume":"16","author":"Jegalian\n              AG,","year":"2009","unstructured":"Jegalian\n              AG, \n            \n              Facchetti\n              F, \n            \n              Jaffe\n              ES. \n          \n          Plasmacytoid dendritic cells: physiologic roles and pathologic states. Adv Anat Pathol. 2009;16(6):392\u2013404."},{"issue":"3","key":"i1543-2165-138-4-564-b17","series-title":"Autoimmunity","first-page":"210","article-title":"Tumoral aspects of plasmacytoid dendritic cells: what do we know in 2009?","volume":"43","author":"Petrella\n              T,","year":"2010","unstructured":"Petrella\n              T, \n            \n              Facchetti\n              F. \n          \n          Tumoral aspects of plasmacytoid dendritic cells: what do we know in 2009?\n          Autoimmunity. 2010;43(3):210\u2013214."},{"issue":"3","key":"i1543-2165-138-4-564-b18","series-title":"Br J Haematol","first-page":"413","article-title":"TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm","volume":"153","author":"Jardin\n              F,","year":"2011","unstructured":"Jardin\n              F, \n            \n              Ruminy\n              P, \n            \n              Parmentier\n              F, \n            et al\n          . TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm. Br J Haematol. 2011;153(3):413\u2013416."},{"issue":"3","key":"i1543-2165-138-4-564-b19","series-title":"Blood","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1182\/blood-2012-08-448613","article-title":"European Group for Blood and Marrow Transplantation Lymphoma, Pediatric Diseases, and Acute Leukemia Working Parties. Stem cell transplantation can provide durable disease control in Blastic plasmacytoid dendritic cell neoplasm (BPDCN) [published online ahead of print November 30, 2012]","volume":"121","author":"Roos-Weil\n              D,","year":"2013","unstructured":"Roos-Weil\n              D, \n            \n              Dietrich\n              S, \n            \n              Boumendil\n              A, \n            et al;\n          \n          European Group for Blood and Marrow Transplantation Lymphoma, Pediatric Diseases, and Acute Leukemia Working Parties. Stem cell transplantation can provide durable disease control in Blastic plasmacytoid dendritic cell neoplasm (BPDCN) [published online ahead of print November 30, 2012]. Blood. 2013;121(3):440\u2013446. doi:10.1182\/blood-2012-08-448613."},{"issue":"11","key":"i1543-2165-138-4-564-b20","series-title":"Haematologica","first-page":"1873","article-title":"Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications","volume":"95","author":"Jegalian\n              AG,","year":"2010","unstructured":"Jegalian\n              AG, \n            \n              Buxbaum\n              NP, \n            \n              Facchetti\n              F, \n            et al\n          . Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications. Haematologica. 2010;95(11):1873\u20131879."}],"container-title":["Archives of Pathology and Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/138\/4\/article-p564.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/138\/4\/564\/2273285\/arpa_2013-0101-rs.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/138\/4\/article-p564.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/138\/4\/article-p564.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:01:34Z","timestamp":1770771694000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/138\/4\/article-p564.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":40,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.5858\/arpa.2013-0101-rs","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}